Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of ARTV will rise by +19.19% over the next 2 Weeks and hit $6.34 by Friday, April 3, 2026. In that time frame, ARTV's share price is expected to range between $5.87 and $6.81.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Apr 3, 2026 | 5.58 | 6.11 | 6.68 |
| Apr 2, 2026 | 5.41 | 5.99 | 6.57 |
| Apr 1, 2026 | 5.45 | 6.01 | 6.55 |
| Mar 31, 2026 | 5.27 | 5.82 | 6.35 |
| Mar 30, 2026 | 5.19 | 5.81 | 6.34 |
| Mar 27, 2026 | 5.15 | 5.72 | 6.29 |
| Mar 26, 2026 | 5.03 | 5.59 | 6.16 |
| Mar 25, 2026 | 5.05 | 5.62 | 6.18 |
| Mar 24, 2026 | 4.88 | 5.42 | 5.96 |
| Mar 23, 2026 | 4.84 | 5.42 | 5.97 |
ARTV shares fell -0.56% in Monday, March 23, 2026's trading session, dropping from a previous close of $5.32 to move at $5.29. The stock demonstrated notable intraday movement (see ARTV's key stats for a full breakdown), fluctuating between $5.25 and $5.41, a +2.95% trading range. While recent weeks have seen some volatility, ARTV has managed to secure a -7.36% drop over the past 2 weeks. The downward price movement was accompanied by decreased trading volume, with approximately 89.08K shares changing hands, 48.09K fewer than the previous session. This amounted to $471.23K in total market activity.
Will ARTV Continue Its Upward Trend?
According to analyst ratings and projections for ARTV, Artiva Biotherapeutics, Inc. shares are anticipated to increase by +20.75%, potentially reaching $6.68 per share by April 3, 2026. Short-term technical indicators for ARTV currently suggest a bullish sentiment. This aligns with the stock's recent performance, as it has recorded 17 positive trading days within the past 30 sessions. Based on the ARTV stock forecast, now is a good time to buy ARTV stock because its current trading price is -13.41% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on ARTV covering social and institutional perspectives.
ARTV Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into ARTV's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 41.04% to 50.67%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 53.13%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 51.79%, maintains a neutral outlook for the long term. Insights into ARTV's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Artiva Biotherapeutics Short-Term Forecasts
ARTV Forecast For Next 5 Days
Our algorithm anticipates Artiva Biotherapeutics (ARTV) stock could hit $5.65 by Mar 30, 2026. This represents a +6.77% fall from today's price, following a -5.33% change over the past five days.
ARTV Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Artiva Biotherapeutics, Inc. (ARTV) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $6.14, which would mean a +16.07% increase from the current price of $5.29. Projections for this period range from a high of $7.58 to a low of $4.66.
ARTV Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Artiva Biotherapeutics's price over the next three months point to a drop. ARTV stock is expected to peak at $11.10 on Mar 23, 2026 before potentially dipping to $0.24 on Apr 16, 2026. On average, ARTV is likely to trade around $3.14 in the coming 90 days.
Artiva Biotherapeutics Stock Forecast 2025
Based on our predictive models, Artiva Biotherapeutics (ARTV) is expected to trade between $0.00 and $11.45 throughout 2026. This would result in an average price of $5.09, potentially offering investors a -3.78% return from current levels.
Artiva Biotherapeutics, Inc. Monthly Forecast 2026–2027
March 2026
According to our latest forecast models, Artiva Biotherapeutics, Inc. (ARTV) is positioned to show a strong performance in March 2026. The price is predicted to move between $7.62 and $11.10, settling at an average of $9.46. This could translate to a +78.83% gain.
April 2026
Based on current market signals, Artiva Biotherapeutics, Inc. is projected to trend april 2026. We forecast a trading range from $0.24 to $7.82, with a likely average price of $2.85. Investors could expect a potential return of -46.12%.
May 2026
Our predictive algorithms indicate Artiva Biotherapeutics, Inc. stock may see a shift in May 2026. The expected range spans $0.91–$3.91, with an average target of $2.17. This represents a cautious outlook and a possible loss of -58.98%.
June 2026
Analyzing established trends, Artiva Biotherapeutics, Inc. looks set to move in June 2026. Projections place the stock between $0.83 and $3.10, averaging around $2.02. This suggests a -61.81% loss from current levels.
July 2026
Market indicators suggest Artiva Biotherapeutics, Inc. could experience notable changes during July 2026. Prices could fluctuate within $0.00 to $4.05, with a midpoint forecast of $2.09. The stock might deliver a -60.49% loss.
August 2026
Forecasting for August 2026, models estimate that Artiva Biotherapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $1.54 and $9.85, averaging $6.20. This signals a positive trajectory with potential returns around +17.20%.
September 2026
According to our latest forecast models, Artiva Biotherapeutics, Inc. (ARTV) is positioned to show a strong performance in September 2026. The price is predicted to move between $2.40 and $9.13, settling at an average of $5.05. This could translate to a -4.54% loss.
October 2026
Based on current market signals, Artiva Biotherapeutics, Inc. is projected to trend october 2026. We forecast a trading range from $3.87 to $10.37, with a likely average price of $7.62. Investors could expect a potential return of +44.05%.
November 2026
Our predictive algorithms indicate Artiva Biotherapeutics, Inc. stock may see a shift in November 2026. The expected range spans $3.70–$10.86, with an average target of $7.65. This represents a positive outlook and a possible gain of +44.61%.
December 2026
Analyzing established trends, Artiva Biotherapeutics, Inc. looks set to move in December 2026. Projections place the stock between $3.80 and $11.45, averaging around $8.74. This suggests a +65.22% gain from current levels.
January 2027
Market indicators suggest Artiva Biotherapeutics, Inc. could experience notable changes during January 2027. Prices could fluctuate within $4.13 to $18.01, with a midpoint forecast of $12.60. The stock might deliver a +138.19% gain.
February 2027
Forecasting for February 2027, models estimate that Artiva Biotherapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $2.41 and $13.03, averaging $7.58. This signals a positive trajectory with potential returns around +43.29%.
March 2027
According to our latest forecast models, Artiva Biotherapeutics, Inc. (ARTV) is positioned to show a strong performance in March 2027. The price is predicted to move between $4.57 and $21.35, settling at an average of $14.17. This could translate to a +167.86% gain.
ARTV's history of dividends and stock splits also plays a role in long-term investor confidence.